Back
Dave Vs. NovoCure Industry Stock Comparison
Buy
78
DAVE
Dave
Last Price:
$117.31
Seasonality Move:
6.21%
Sell
36
NVCR
NovoCure
Last Price:
$22.47
Seasonality Move:
8.65%
Sell
36
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.01 | Buy |
Relative Strength Index (14 RSI): | 67.46 | Buy |
Chaikin Money Flow: | 353367 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.86 - 105.56) | Buy |
Bollinger Bands (100): | (49.02 - 98.48) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.47 | Sell |
Relative Strength Index (14 RSI): | 36.42 | Sell |
Chaikin Money Flow: | 174506 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.72 - 26.76) | Sell |
Bollinger Bands (100): | (16.17 - 28.17) | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.96 | Buy |
20-day SMA: | 99.02 | Buy |
50-day SMA: | 93.43 | Buy |
200-day SMA: | 56.06 | Buy |
8-day EMA: | 107.81 | Buy |
20-day EMA: | 101.17 | Buy |
50-day EMA: | 91.64 | Buy |
200-day EMA: | 62.11 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.22 | Buy |
20-day SMA: | 24.25 | Sell |
50-day SMA: | 27.48 | Sell |
200-day SMA: | 20.53 | Buy |
8-day EMA: | 22.39 | Buy |
20-day EMA: | 23.92 | Sell |
50-day EMA: | 24.72 | Sell |
200-day EMA: | 22.15 | Buy |
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $1.04 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.03 per share.
Dave Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |